EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Tumor-derived Exosomes and Antitumor Immunity

Theresa L Whiteside iD

The Journal of Immunology · 01.10.2024 · 213 (7) · 923-931

DOI: 10.4049/jimmunol.2400335 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 01.10.2024. Verfasst von Theresa L Whiteside. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Immunology, University of Pittsburgh School of Me…. Hauptthemen laut MEDLINE: Exosomes, Neoplasms, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, empty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy, including immune checkpoint blockade, has been approved for treatment of patients with many cancer types. However, some patients fail to respond to immunotherapy, and emerging evidence indicates that tumor-derived exosomes (TEX) play a major role in reprogramming the host immune cells by inducing their dysfunction. Focusing on effector T cells, this review illustrates mechanisms of suppression that TEX use, thus promoting tumor escape from the host immune system. TEX carry multiple suppressive signals that drive T cell dysfunction and convert the tumor microenvironment into “an immune desert” in which activated T cells either die or are reprogrammed to mediate protumor functions. The reprogrammed T cells produce a new crop of CD3+ immunoinhibitory exosomes that further amplify suppression mediated by TEX. The result is a profound depletion of antitumor immune effector cells that reflects the defective immune competence of the cancer patient and partly explains why TEX are a significant barrier for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesNeoplasmsTumor MicroenvironmentImmunotherapyHumansAnimalsTumor EscapeT-Lymphocytes

Autor:innen und Institutionen

  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA; and UPMC Hillman Cancer Center, Pittsburgh, PA.

ORCID-Profile: Theresa L Whiteside

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • empty

Zitieren

APA

Whiteside, T. L. (2024). Tumor-derived Exosomes and Antitumor Immunity. The Journal of Immunology, 213(7), 923-931. https://doi.org/10.4049/jimmunol.2400335

Vancouver

Whiteside TL. Tumor-derived Exosomes and Antitumor Immunity. The Journal of Immunology. 2024;213(7):923-931. doi:10.4049/jimmunol.2400335

BibTeX
@article{Whiteside2024,
  author = {Whiteside, Theresa L},
  title = {Tumor-derived Exosomes and Antitumor Immunity},
  journal = {The Journal of Immunology},
  year = {2024},
  volume = {213},
  number = {7},
  pages = {923--931},
  doi = {10.4049/jimmunol.2400335}
}
Kostenlos starten →